Suppr超能文献

用于在小鼠中测试候选镇痛剂的行为学电池。I. 阳性和阴性对照的验证。

Behavioral Battery for Testing Candidate Analgesics in Mice. I. Validation with Positive and Negative Controls.

机构信息

Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA.

Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA

出版信息

J Pharmacol Exp Ther. 2021 May;377(2):232-241. doi: 10.1124/jpet.120.000464. Epub 2021 Feb 23.

Abstract

This study evaluated a battery of pain-stimulated, pain-depressed, and pain-independent behaviors for preclinical pharmacological assessment of candidate analgesics in mice. Intraperitoneal injection of dilute lactic acid (IP acid) served as an acute visceral noxious stimulus to produce four pain-related behaviors in male and female ICR mice: stimulation of 1) stretching, 2) facial grimace, 3) depression of rearing, and 4) depression of nesting. Additionally, nesting and locomotion in the absence of the noxious stimulus were used to assess pain-independent drug effects. These six behaviors were used to compare effects of two mechanistically distinct but clinically effective positive controls (ketoprofen and oxycodone) and two negative controls that are not clinically approved as analgesics but produce either general motor depression (diazepam) or motor stimulation (amphetamine). We predicted that analgesics would alleviate all IP acid effects at doses that did not alter pain-independent behaviors, whereas negative controls would not. Consistent with this prediction, ketoprofen (0.1-32 mg/kg) produced the expected analgesic profile, whereas oxycodone (0.32-3.2 mg/kg) alleviated all IP acid effects except depression of rearing at doses lower than those that altered pain-independent behaviors. For the negative controls, diazepam (1-10 mg/kg) failed to block IP acid-induced depression of either rearing or nesting and only decreased IP acid-stimulated behaviors at doses that also decreased pain-independent behaviors. Amphetamine (0.32-3.2 mg/kg) alleviated all IP acid effects but only at doses that also stimulated locomotion. These results support utility of this model as a framework to evaluate candidate-analgesic effects in a battery of complementary pain-stimulated, pain-depressed, and pain-independent behavioral endpoints. SIGNIFICANCE STATEMENT: Preclinical assays of pain and analgesia often yield false-positive effects with candidate analgesics. This study used two positive-control analgesics (ketoprofen, oxycodone) and two active negative controls (diazepam, amphetamine) to validate a strategy for distinguishing analgesics from nonanalgesics by profiling drug effects in a battery of complementary pain-stimulated, pain-depressed, and pain-independent behaviors in male and female mice.

摘要

本研究评估了一系列疼痛刺激、疼痛抑制和与疼痛无关的行为,以对候选镇痛药物在小鼠中的临床前药理学进行评估。腹腔内注射稀释的乳酸(IP 酸)作为急性内脏疼痛刺激物,可在雄性和雌性 ICR 小鼠中产生四种与疼痛相关的行为:1)伸展刺激,2)面部痛苦表情,3)抬举抑制,4)筑巢抑制。此外,在没有疼痛刺激的情况下进行筑巢和运动,以评估与疼痛无关的药物作用。这六种行为用于比较两种机制上不同但临床上有效的阳性对照物(酮洛芬和羟考酮)和两种不是临床上批准的镇痛药但产生要么是一般性运动抑制(地西泮)要么是运动刺激(安非他命)的阴性对照物的作用。我们预测,在不改变与疼痛无关的行为的情况下,镇痛药会缓解所有 IP 酸的作用,而阴性对照物则不会。与这一预测一致,酮洛芬(0.1-32mg/kg)产生了预期的镇痛作用,而羟考酮(0.32-3.2mg/kg)缓解了除了抑制抬举之外的所有 IP 酸作用,其剂量低于改变与疼痛无关的行为的剂量。对于阴性对照物,地西泮(1-10mg/kg)未能阻止 IP 酸诱导的抬举或筑巢抑制,仅在降低 IP 酸刺激行为的剂量下降低 IP 酸刺激的行为。安非他命(0.32-3.2mg/kg)缓解了所有 IP 酸的作用,但仅在刺激运动的剂量下。这些结果支持将该模型作为一种框架,用于在一系列互补的疼痛刺激、疼痛抑制和与疼痛无关的行为终点中评估候选镇痛药物的效果。

意义

疼痛和镇痛的临床前检测经常会导致候选镇痛药产生假阳性效应。本研究使用两种阳性对照镇痛药(酮洛芬、羟考酮)和两种活性阴性对照物(地西泮、安非他命),通过在雄性和雌性小鼠中一系列互补的疼痛刺激、疼痛抑制和与疼痛无关的行为中对药物作用进行分析,来区分镇痛药和非镇痛药,验证了一种策略的有效性。

相似文献

1
Behavioral Battery for Testing Candidate Analgesics in Mice. I. Validation with Positive and Negative Controls.
J Pharmacol Exp Ther. 2021 May;377(2):232-241. doi: 10.1124/jpet.120.000464. Epub 2021 Feb 23.
5
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Oxycodone for neuropathic pain and fibromyalgia in adults.
Cochrane Database Syst Rev. 2014 Jun 23(6):CD010692. doi: 10.1002/14651858.CD010692.pub2.
7
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3.
8
Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews.
Cochrane Database Syst Rev. 2015 Sep 28;2015(9):CD008659. doi: 10.1002/14651858.CD008659.pub3.
9
Single dose oral ketoprofen or dexketoprofen for acute postoperative pain in adults.
Cochrane Database Syst Rev. 2017 May 25;5(5):CD007355. doi: 10.1002/14651858.CD007355.pub3.
10
Oral analgesia for relieving post-caesarean pain.
Cochrane Database Syst Rev. 2015 Mar 29;2015(3):CD010450. doi: 10.1002/14651858.CD010450.pub2.

引用本文的文献

6
Neuropathic pain; what we know and what we should do about it.
Front Pain Res (Lausanne). 2023 Sep 22;4:1220034. doi: 10.3389/fpain.2023.1220034. eCollection 2023.
7
Climbing behavior by mice as an endpoint for preclinical assessment of drug effects in the absence and presence of pain.
Front Pain Res (Lausanne). 2023 Apr 17;4:1150236. doi: 10.3389/fpain.2023.1150236. eCollection 2023.
8
Morphine Exacerbates Experimental Colitis-Induced Depression of Nesting in Mice.
Front Pain Res (Lausanne). 2021 Dec 13;2:738499. doi: 10.3389/fpain.2021.738499. eCollection 2021.
9
Opioid-like adverse effects of tianeptine in male rats and mice.
Psychopharmacology (Berl). 2022 Jul;239(7):2187-2199. doi: 10.1007/s00213-022-06093-w. Epub 2022 Feb 24.

本文引用的文献

2
'Reinventing the wheel' to advance the development of pain therapeutics.
Behav Pharmacol. 2021 Apr 1;32(2&3):142-152. doi: 10.1097/FBP.0000000000000596.
3
The search for translational pain outcomes to refine analgesic development: Where did we come from and where are we going?
Neurosci Biobehav Rev. 2020 Jun;113:238-261. doi: 10.1016/j.neubiorev.2020.03.004. Epub 2020 Mar 5.
4
Experimental design and analysis for consideration of sex as a biological variable.
Neuropsychopharmacology. 2019 Dec;44(13):2159-2162. doi: 10.1038/s41386-019-0458-9. Epub 2019 Jul 5.
5
A standardised framework to identify optimal animal models for efficacy assessment in drug development.
PLoS One. 2019 Jun 13;14(6):e0218014. doi: 10.1371/journal.pone.0218014. eCollection 2019.
6
Core Outcome Measures in Preclinical Assessment of Candidate Analgesics.
Pharmacol Rev. 2019 Apr;71(2):225-266. doi: 10.1124/pr.118.017210.
7
Pros and Cons of Clinically Relevant Methods to Assess Pain in Rodents.
Neurosci Biobehav Rev. 2019 May;100:335-343. doi: 10.1016/j.neubiorev.2019.03.009. Epub 2019 Mar 15.
8
Characterization of Cancer-Induced Nociception in a Murine Model of Breast Carcinoma.
Cell Mol Neurobiol. 2019 Jul;39(5):605-617. doi: 10.1007/s10571-019-00666-8. Epub 2019 Mar 8.
9
Effects of monoamine uptake inhibitors on pain-related depression of nesting in mice.
Behav Pharmacol. 2019 Sep;30(6):463-470. doi: 10.1097/FBP.0000000000000469.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验